相关实验视频

Updated: Jan 16, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

研究帕金森病中淋巴功能障碍和运动症状之间的关系

Xinhui Ma¹, Ruifang Yan², Yangyang Jian¹

¹Department of Medical Imaging Center, The First Affiliated Hospital of Henan Medical University, 88 Healthy Road, Weihui, Xinxiang, 453100, China.

European journal of medical research

|September 27, 2025

概括

通过沿周血管空间 (DTI-ALPS) 测量扩散张力图像分析 (DTI-ALPS) 测量的大脑废物清除受损与帕金森病 (PD) 运动症状有关. 在PD患者中,较低的DTI-ALPS得分与运动障碍的增加相关,这表明其作为生物标志物的潜力.

科学领域:

神经科学是一个神经科学.
放射学放射学是一门学科.
生物标志物生物标志物

背景情况:

淋巴系统促进大脑的废物清除,这对于预防神经退行至关重要.
淋巴功能受损与帕金森病 (PD) 病原发生有关.
淋巴功能障碍与PD运动症状严重程度之间的联系需要进一步阐明.

研究的目的:

对帕金森病患者的淋巴系统功能和运动障碍之间的关系进行调查.
评估扩散张力图像分析沿周周血管空间 (DTI-ALPS) 指数作为PD运动缺陷的成像生物标志物的潜力.
为了比较PD患者和健康对照 (HCs) 之间的DTI-ALPS值.

主要方法:

沿周血管空间 (DTI-ALPS) 采用扩散张力图像分析来量化大脑废物清理网络活动.
招募了43名PD患者和31名健康对照 (HC) 进行MRI扫描.
使用运动障碍学会统一帕金森病评级表 (MDS-UPDRS) 评估运动症状,并分析与DTI-ALPS指数的相关性.

主要成果:

与HC相比,PD患者的DTI-ALPS值显著较低 (p=0.019),表明清除功能的减少.
该DTI-ALPS指数显示了与总MDS-UPDRS得分 (r=-0.418,p=0.005) 和运动子部分得分 (r=-0.424,p=0.005) 的显著反向相关性.
DTI-ALPS指标独立预测了运动症状严重程度,占变化率的14.6% (ΔR2=0.008).

结论:

降低的DTI-ALPS指数与帕金森病中大脑废物清理受损有关.
在PD患者中,DTI-ALPS指标与运动残疾有显著的相关性.
这些发现支持DTI-ALPS作为神经成像生物标志物的潜在实用性,用于评估帕金森病中运动障碍.

关键词:

根据DTI-ALPS指数进行分析.淋巴管路径的淋巴管路径.运动表现的运动表现.帕金森病是帕金森氏症的一种疾病.

更多相关视频

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...